logo-loader
NASDAQ:AYTU

Aytu BioScience Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$23.16 m
Price
$1.40
Change
-0.71%
52 weeks high
4.80
52 weeks low
0.69

Filter by article type

Viewing results 1-5 of 5

Health

Aytu BioScience gains on licensing deal to distribute sleep aid outside the US and Canada

The deal calls for SUDA Pharmaceuticals of Perth, Australia, to lead commercial development and sublicensing efforts for ZolpiMist in Europe, Asia and Latin America...

on 7/3/19
Health

Histogenics, Aytu BioScience and KenPharm shares tumble on share offerings

All three stocks suffered some of the biggest losses in NASDAQ during the session...

on 6/10/18
Industry & services

Aytu's first steps into $2bln testosterone market

Natesto is the first nasal formulation of testosterone approved by the US Food and Drug Administration...

on 25/4/16
Industry & services

Aytu BioScience Inc gets approval for male infertility diagnostics

Aytu’s new urology product MiOXSYS, a system that assesses the level of oxidative stress in semen, can now be marketed in Canada....

on 1/4/16